Re: Biogen looks to FDA for approval of early Alzheimers drug.
in response to
by
posted on
Oct 22, 2019 12:40PM
,,,,,anyone watching the value being placed on Biogens push for approval,,,,,,,,so far I see BIIB and their partner ESALY have moved up a total today in market cap ruffly about,,,,,,$20 billion,,,,imagine if our data is more impressive,,,,,,,,,,,,,